KTE-C19, an Anti-CD19 Chimeric Antigen an Anti-CD19 Chimeric Antigen Receptor (CAR) T cell Therapy in Adult Patients (Pts) With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the ZUMA-3 Trial: Preliminary Results of Novel Safety Interventions
作者
Bijal Shah,Wendy Stock,William G. Wierda,Max S. Topp,Marie José Kersten,Roch Houot,Nicolas Boissel,Houston Holmes,Gary J. Schiller,Armen Mardiros,John M. Rossi,Yizhou Jiang,Tong Shen,Jeff Aycock,Shanna Stout,Jeff Wiezorek,Rajul K. Jain